Sainz de la Maza, S.; Walo-Delgado, P.E.; RodrÃguez-DomÃnguez, M.; Monreal, E.; Rodero-Romero, A.; Chico-GarcÃa, J.L.; Pariente, R.; RodrÃguez-Jorge, F.; Ballester-González, R.; Villarrubia, N.;
et al. Short- and Long-Term Humoral and Cellular Immune Responses to SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis Treated with Disease-Modifying Therapies. Vaccines 2023, 11, 786.
https://doi.org/10.3390/vaccines11040786
AMA Style
Sainz de la Maza S, Walo-Delgado PE, RodrÃguez-DomÃnguez M, Monreal E, Rodero-Romero A, Chico-GarcÃa JL, Pariente R, RodrÃguez-Jorge F, Ballester-González R, Villarrubia N,
et al. Short- and Long-Term Humoral and Cellular Immune Responses to SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis Treated with Disease-Modifying Therapies. Vaccines. 2023; 11(4):786.
https://doi.org/10.3390/vaccines11040786
Chicago/Turabian Style
Sainz de la Maza, Susana, Paulette Esperanza Walo-Delgado, Mario RodrÃguez-DomÃnguez, Enric Monreal, Alexander Rodero-Romero, Juan Luis Chico-GarcÃa, Roberto Pariente, Fernando RodrÃguez-Jorge, Rubén Ballester-González, Noelia Villarrubia,
and et al. 2023. "Short- and Long-Term Humoral and Cellular Immune Responses to SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis Treated with Disease-Modifying Therapies" Vaccines 11, no. 4: 786.
https://doi.org/10.3390/vaccines11040786
APA Style
Sainz de la Maza, S., Walo-Delgado, P. E., RodrÃguez-DomÃnguez, M., Monreal, E., Rodero-Romero, A., Chico-GarcÃa, J. L., Pariente, R., RodrÃguez-Jorge, F., Ballester-González, R., Villarrubia, N., Romero-Hernández, B., Masjuan, J., Costa-Frossard, L., & Villar, L. M.
(2023). Short- and Long-Term Humoral and Cellular Immune Responses to SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis Treated with Disease-Modifying Therapies. Vaccines, 11(4), 786.
https://doi.org/10.3390/vaccines11040786